Biomira is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Biomira's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients.
Forward Looking Statements
In order to provide Biomira's investors with an understanding of its current intentions and future prospects, this release contains statements that are forward looking, including statements relating to court approval of the proposed reincorporation of Biomira from Canada to the United States, the timing and benefits thereof and future clinical development plans. These forward-looking statements represent Biomira's intentions, plans, expectations and beliefs and are based on its management's experience and assessment of historical and future trends and the application of key assumptions relating to future events and circumstances.
Forward-looking statements involve risks and uncertainties, including
risks and uncertainties related to the proposed reincorporation
transaction, Biomira's business and the general economic environment. Many
of these risks and uncertainties are beyond Biomira's control. These risks,
uncertainties and other factors could cause our actual results to differ
materially from those projected in forward-looking statements. Risks,
uncertainties, and assumptions include those predicting the completion and
benefits of the proposed arrangement and reincorporation; future clinical
development plans; and the other risks and uncertainties described in the
reports and other documents, including the registr
|SOURCE Biomira Inc.|
Copyright©2007 PR Newswire.
All rights reserved